KISQALI® (ribociclib) for HR+, HER2- Metastatic Breast Cancer
WEBLearn about HR+, HER2- metastatic breast cancer treatment in premenopausal and postmenopausal women with KISQALI. See full Prescribing & Safety Info.
Kisqali: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBSep 25, 2023 · Kisqali is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Kisqali is used to treat hormone-related breast cancer in women. Ribociclib is used only if your cancer tests negative for a protein called human epidermal growth factor receptor 2 (HER2).
Kisqali: What to Expect, Side Effects, and More - Breastcancer.org
WEBJul 18, 2024 · Kisqali (ribociclib) is a CDK4/6 inhibitor used to treat certain people with advanced-stage or metastatic estrogen-receptor-positive, HER2-negative breast cancer.
How KISQALI® (ribociclib) Works
WEBLearn how KISQALI can work as a possible HR+, HER2- metastatic breast cancer treatment combined with hormone therapy. See full Prescribing & Safety Info.
Kisqali: Dosage, Side Effects, Uses, and More - Healthline
WEBSep 13, 2023 · Kisqali (ribociclib) is a prescription drug that’s used to treat breast cancer. Kisqali comes as a tablet that you swallow. Kisqali is prescribed for adults to treat HR-positive and...
Ribociclib - Wikipedia
WEBRibociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib is a kinase inhibitor. It was developed by Novartis and Astex Pharmaceuticals.
Overall Survival Results with KISQALI® (ribociclib)
WEBLearn about clinical trial results in women living with HR+, HER2- metastatic breast cancer who were treated with KISQALI. See full Prescribing & Safety Info.
Ribociclib: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBJul 19, 2024 · Ribociclib (Kisqali) is a targeted treatment used to treat advanced breast cancer that is hormone receptor-positive and HER2-negative. Includes ribociclib side effects, uses, doses, and interactions.
Kisqali oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
WEBFind patient medical information for Kisqali oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Kisqali Plus Hormone Therapy for Metastatic Breast Cancer
WEBJan 11, 2023 · In pre- and perimenopausal women with breast cancer, combining ribociclib (Kisqali) and hormone therapy was more effective at halting the growth of metastatic tumors than standard treatment with a combination of chemotherapy drugs.
- Some results have been removed
Skip to content